ПРЕДИАБЕТ: ДИАГНОСТИКА ДИСГЛИКЕМИИ, МЕТАБОЛОМИКА
Обзорная статья
Дата публикации: января 13, 2021
Ключевые слова
дисгликемия
предиабет
метаболомика
предиабет
метаболомика
Как цитировать
[1]
.
Аннотация
Обзорная статья посвящена проблеме ранней диагностики предиабета, методам выявления гликемических расстройств. В статье анализируются публикации, содержащие новую информацию о метаболомике и ее преимуществах перед традиционными методами. Авторы использовали электронные базы научных данных (PubMed, Web on Science, eLibrary.ru, ScienceDirect, Cochrane Library), систематизировали результаты исследований.Литература
1. Bansal N. Prediabetes diagnosis and treatment: A review //World journal of diabetes. – 2015. – V.6. - №2. – P. 296–303. doi:10.4239/wjd.v6.i2.296.
2. Wilson M.L. Prediabetes: Beyond the Borderline //Nurs. Clin. North. Am. - 2017 Dec;52(4):665-677. doi: 10.1016/j.cnur.2017.07.011.
3. Makaroff L.E. The need for international consensus on prediabetes //The lancet Diabetes & endocrinology. – 2017. - V.5. – P. 5–7. doi: 10.1016/S2213-8587(16)30328-X.
4. Punthakee Z., Goldenberg R., Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome //Canadian journal of diabetes. – 2018. – V.42 (Suppl. 1). - S10-S15. doi: 10.1016 /j.jcjd.2017.10.003.
5. Classification and Diagnosis of Diabetes. American Diabetes Association //Diabetes Care. – 2017. V.40 (Suppl.1). - S11-S24. doi:10.2337/dc17-S005.
6. Недогода С.В. и др. Преддиабет: Основные причины, симптомы, профилактика и лечение //Лекарственный вестник. – 2018. - Т. 12. - №. 2 (70). - С.3-13. [Nedogoda S.V. et al. Prediabetes: Main Causes, Symptoms, Prevention and Treatment //Lekarstvennyj vestnik (Medicinal Bulletin). - 2018. - V. 12. - №. 2 (70). - P. 3-13. In Russian].
7. Барбараш О.Л. и др. Предиабет как междисциплинарная проблема: определение, риски, подходы к диагностике и профилактике сахарного диабета 2 типа и сердечно-сосудистых осложнений //Российский кардиологический журнал. – 2019. – Т. 24. - №. 4. - С. 83–91. [Barbarash O.L. et al. Pre-diabetes as an interdisciplinary problem: definition, risks, approaches to the diagnostics and prevention of type 2 diabetes and cardiovascular complications //Rossijskij kardiologicheskij zhurnal (Russian Journal of Cardiology). - 2019. - V. 24. - №. 4. - P. 83–91. In Russian]. doi: 10.15829 /1560-4071-2019-4-83-91.
8. Warren B. et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study //The Lancet Diabetes & endocrinology. – 2017. – №. 5. – P. 34–42. doi: 10.1016/S2213-8587(16)30321-7.
9. Richter B. et al. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia ('prediabetes') //Cochrane Database of Systematic Reviews. – 2018. – № 10. doi: 10.1002/14651858.CD012661.pub2.
10. Kuehn B. Prediabetes in Youth //Jama. – 2020. – V.323. - №4. – P.302. doi: 10.1001/jama.2019.21122.
11. Meijnikman A.S. et al. Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome // Diabetology & metabolic syndrome. – 2018. – V. 10. – P. 12. doi: 10.1186/s13098-018-0310-0.
12. Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance. National Diabetes Data Group //Diabetes. – 1979. – V. 28. - № 12. – P. 1039-1057. doi: 10.2337/diab.28.12.1039.
13. Mukai N. et al. Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study //Cardiovascular diabetology. – 2014. – V.13. – №. 1. – P. 1-10. doi: 10.1186/1475-2840-13-45.
14. Sallar A., Dagogo-Jack S. Regression from prediabetes to normal glucose regulation: State of the science //Experimental Biology and Medicine. - 2020. – V. 245. - № 10. - P. 889-896. doi: 10.1177/1535370220915644.
15. Abdul-Ghani M.A., Tripathy D., DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose //Diabetes Care. – 2006. – V. 29. P. 1130–1139. doi: 10.2337/dc05-2179.
16. Unwin N. et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. //Diabetic medicine. – 2002. – V.19. – № 9. - P. 708–723. doi: 10.1046/j.1464-5491.2002.00835.x.
17. Genuth S. et al. Follow-up report on the diagnosis of diabetes mellitus //Diabetes Care. – 2003. – V. 26. - P.3160–3167. doi: 10.2337/diacare.26.11.3160.
18. Abdul-Ghani M.A. et al. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study //Diabetes. – 2006. – V.55. – P. 1430–1435. doi: 10.2337/db05-1200.
19. Soderberg S. et al. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius //Journal of internal medicine. – 2004. – V. 256. – P. 37–47. doi: 10.1111/j.1365-2796.2004.01336.x.
20. DeFronzo R.A., Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose //The American journal of cardiology. – 2011. – V. 108. – P. 3B–24B. doi: 10.1016/j.amjcard.2011.03.013.
21. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group //Diabetes. – 1979. – V. 28. – P. 1039–1057.
22. Stern K.G., Reiner M., Silber R.T.H. On the Electrophoretic Pattern of Red Blood Cell Proteins. A preliminary study //Journal of Biological Chemistry. - 1945. – V. 161. - P.731-738.
23. Kunkel H., Wallenius G. New hemoglobins in normal adult blood //Science. – 1955. – V. 122. – Iss. 3163. – P. 288. doi: 10.1126/science.122.3163.288
24. Аllen D.W., Schroeder W.A., Balog J. Observations on the Chromatographic Heterogeneity of Normal Adult and Fetal Human Hemoglobin: A Study of the Effects of Crystallization and Chromatography on the Heterogeneity and Isoleucine Content //Journal of the American Chemical Society. - 1958. – V. 80. – P. 1628–1634. doi: 10.1021/ja01540a030.
25. Huisman T.H., Martis E.A., Dozy A. Chromatography of Hemoglobin Types on Carboxymethylcellulose //The Journal of laboratory and clinical medicine. – 1958. – V.52. - №2. - P. 312-327.
26. Rahbar S. An Abnormal Hemoglobin in Red Cells of Diabetics //Clinica chimica acta. – 1968. – V.22. - №. 2. - P. 296-298. doi: 10.1016/0009-8981(68)90372-0.
27. Koenig R.J. et al. Hemoglobin A1C as an indicator of the degree of glucose intolerance in diabetes //Diabetes. – 1976. – V. 25. - P. 230–232. doi: 10.2337/diab.25.3.230.
28. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. The International Expert Committee //Diabetes Care. -2009. – V.32. - №. 7. - P. 1324-1334. doi: 10.2337/dc09-9033.
29. Топунов А.Ф., Космачевская О.В. Множественные функциональные формы гемоглобина в организме человека: современный взгляд и практическое использование //Биомика. - 2018. - Т.10. - №3 - С. 251-267. [Topunov A.F., Kosmachevskaya O.V. Multiple hemoglobin functional forms in human organism: the modern view and practical applications //Biomika (Biomics). - 2018. - V.10 - №3. - P. 251-267. In Russian]. doi: 10.31301/2221-6197.bmcs.2018-34.
30. Kanat M. et al. The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study //Diabetes Care. – 2011. – V. 34. – P. 1006–1010. https://doi.org/10.2337/dc10-1352.
31. Tfayli H., Lee S.J., Bacha F., Arslanian S. One-hour plasma glucose concentration during the OGTT: what does it tell about beta-cell function relative to insulin sensitivity in overweight/obese children? //Pediatric Diabetes. – 2011. – V. 12. – P. 572–579. doi: 10.1111/j.1399-5448.2011.00745.x.
32. Fiorentino T.V. et al. One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes //The Journal of Clinical Endocrinology & Metabolism. – 2018. – V. 103. – P. 3131 –3143. doi: 10.1210/JC.2016-1856.
33. Bergman M. et al. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥155mg/dl (8.6 mmol/L). //Diabetes research and clinical practice. – 2018. – V. 146. P. 18–33. doi: 10.1016/j.diabres.2018.09.017.
34. Abdul-Ghani M.A. et al. Onehour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes //Diabetes Care. – 2008. – V. 31. – P. 1650–1655. doi: 10.2337/dc08-0225.
35. Alyass A. et al. Modelling of OGTT curve identifies 1-h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts //Diabetologia. – 2015. – V. 58. – P. 87–97. doi: 10.1007/s00125-014-3390-x.
36. Paddock E. et al. One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans //Diabetologia. – 2017. – V. 60. - P. 1704–1711. doi: 10.1007/s00 125-017-4332-1.
37. Prasanna N. S. et al. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects //Journal of Diabetes and its Complications. - 2017. – V. 31. – P. 1592–1596. doi: 10.1016/j.jdiacomp.2017.07. 017.
38. Manco M. et al. One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort //Diabetologia. – 2019. – V. 62. – P. 544–548. doi: 10.1007/s00125-018-4798-5.
39. Trico D. et al. Intestinal Glucose Absorption Is a Key Determinant of 1-Hour Postload Plasma Glucose Levels in Nondiabetic Subjects //The Journal of Clinical Endocrinology & Metabolism. – 2019. – V. 104. – P. 2131–2139. doi: 10.1210/jc.2018-02166.
40. Fiorentino N.V. et al. Response to Letter to the Editor: «One-Hour Postload Hyperglycemia: Implications for Prediction andPrevention of Type 2 Diabetes» //The Journal of Clinical Endocrinology & Metabolism. – 2019. – V. 104. - №. 3. – P. 676–677. doi: 10.1210/jc.2018-01824.
41. Трифонова О.П. и др. Метаболомный анализ крови для создания цифрового образа здорового человека //Биомедицинская химия. – 2020. – Т. 66. - №. 3. - С. 216-223. [Trifonova O.P. et al. The blood metabolome analysis for creating a digital image of a healthy person. //Biomeditsinskaya khimiya (Biomedical chemistry). – 2020. – V.66. - №3. - P. 216-223. In Russian] doi: 10.18097/ PBMC20206603216.
42. Balashova E.E. et al. Metabolomic diagnostics and human digital image // Personalized medicine. - 2019. – V. 16. - №. 2. – P. 133-144. doi:10.2217/pme-2018-0066.
43. Liu J. et al. Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study //Metabolomics. – 2017. - V. 13. – №. 9. – P. 104. doi: 10.1007 /s11306-017-1239-2.
44. Bos M.M. et al. Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivity //Metabolomics. – 2020. – V. 16. - №. 3. – P. 35. doi: 10.1007/s11306-020-01653-7.
45. Tolstikov V. et al. Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics //Metabolites. – 2020. – V.10. - №6. - P. 224. doi: 10.3390/metabo10060224.
46. Лохов П.Г., Лисица А.В., Арчаков А.И. Метаболомный анализ крови: назначение, реализация, интерпретация данных //Биомедицинская химия. - 2017. - Т. 63. - №. 3. - С. 232-240. [Lokhov P.G., Lisitsa A.V., Archakov A.I. Metabolomic blood test: purpose, implementation and findings interpretation //Biomedicinskaya himiya (Biomedical Chemistry). - 2017. - V. 63. - №. 3. - P. 232-240. In Russian]. doi: 10.18097/PBMC20176303232.
47. Трифонова O.П., Лохов П.Г., Арчаков А.И. Метаболомное профилирование крови //Биомедицинская химия. – 2014. – Т. 60. - №. 3. - С. 281-294. Trifonova O.P., Lokhov P.G., Archakov A.I. Metabolic profiling of human blood // Biomedicinskaya himiya (Biomedical Chemistry). - 2014. - V. 60. - №. 3. - P. 281-294. In Russian]. doi: 10.18097/pbmc20146003281.
48. Guasch-Ferre M. et al. Metabolomics in Prediabetes and Diabetes: A Systematic Review and Metaanalysis //Diabetes Care. – 2016. – V. 39. – P. 833–846. doi: 10.2337/dc15-2251.
49. Menni C. et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach //Diabetes. – 2013. – V. 62. – P. 4270–4276. doi: 10.2337/db13-0570.
50. Xu F. et al. Tavintharan S., Sum C.F., Woon K., Lim S.C., Ong C.N. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics //The Journal of Clinical Endocrinology & Metabolism. – 2013. – V. 98. - №. 6. – P. E1060–1065. doi: 10.1210/jc.2012-4132
51. Sun L. et al. Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study //Diabetes Care. - 2016. – V. 39. - P. 1563–1570. doi: 10.2337/dc16-0232.
52. Weijer R.N.M. Fundamentals about onset and progressive disease character of type 2 diabetes mellitus //World Journal of Diabetes. – 2020. – V. 11. - № 5. – P. 165–181. doi: 10.4239/wjd. v11.i5.165.
53. Drogan D. et al. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetesmellitus in a prospective, nested case control study //Clinical chemistry. – 2015. – V. 61. - P. 487–497. doi: 10.1373/clinchem.2014. 228965.
54. Peddinti G. et al. 1-Hour Post-OGTT Glucose Improves the Early Prediction of Type 2 Diabetes by Clinical and Metabolic Markers //The Journal of Clinical Endocrinology & Metabolism. – 2019. - V.104. - №. 4. – P. 1131–1140. doi: 10.1210/jc.2018-01828.
55. Liu X. et al. Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS //Clinical Biochemistry. – 2020. – V. 82. - P. 40-50. doi: 10.1016/j.clinbiochem.2020.03.007.
56. Hasanpour M., Iranshahy M., Iranshahi M. The application of metabolomics in investigating anti-diabetic activity of medicinal plants //Biomedicine & Pharmacotherapy. – 2020. – V. 128. – P.110263. doi: 10.1016/j.biopha.2020. 110263.
57. Xu Y. J., Liu Y. Metabolomics to Study the Therapeutic Value of Natural Compounds to Treat Obesity, Reference Module in Food Science, Elsevier, 2020. doi:10.1016/b978-0-08-100596-5.22885-0.
58. Wishart D. S. NMR metabolomics: A look ahead //Journal of Magnetic Resonance. – 2019. - V. 306. – P. 155-161. doi: 10.1016/j.jmr.2019.07.013.
59. Ismailov A. S., Kuspaev E. N., Fursov A. B. Analysis of the reasons of development of lethal cases of surgical patients //The FASEB Journal. – 2015. – V. 29. – №. 1 supplement. – P. LB686. doi: 10.1096/fasebj.29.1_supplement.C. LB686.
60. Imashev M. et al. Gastroduodenal Bleeding and Perforation in Diabetic Patients with Metabolic Syndrome (The Results of a 15-Year Observation of City Residents with Intensive Urbanization) //Iranian Journal of Public Health. – 2019. – V. 48. – №. 10. – P. 1786-1793. doi: 10.18502/ijph.v48i10.3484
61. Bergman M. et al. Review of methods for detecting glycemic disorders //Diabetes Research and Clinical Practice. – 2020. – V. 165. – N. 108233. – P. 1 – 34. doi: 10.1016/j.diabres.2020.108233.
2. Wilson M.L. Prediabetes: Beyond the Borderline //Nurs. Clin. North. Am. - 2017 Dec;52(4):665-677. doi: 10.1016/j.cnur.2017.07.011.
3. Makaroff L.E. The need for international consensus on prediabetes //The lancet Diabetes & endocrinology. – 2017. - V.5. – P. 5–7. doi: 10.1016/S2213-8587(16)30328-X.
4. Punthakee Z., Goldenberg R., Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome //Canadian journal of diabetes. – 2018. – V.42 (Suppl. 1). - S10-S15. doi: 10.1016 /j.jcjd.2017.10.003.
5. Classification and Diagnosis of Diabetes. American Diabetes Association //Diabetes Care. – 2017. V.40 (Suppl.1). - S11-S24. doi:10.2337/dc17-S005.
6. Недогода С.В. и др. Преддиабет: Основные причины, симптомы, профилактика и лечение //Лекарственный вестник. – 2018. - Т. 12. - №. 2 (70). - С.3-13. [Nedogoda S.V. et al. Prediabetes: Main Causes, Symptoms, Prevention and Treatment //Lekarstvennyj vestnik (Medicinal Bulletin). - 2018. - V. 12. - №. 2 (70). - P. 3-13. In Russian].
7. Барбараш О.Л. и др. Предиабет как междисциплинарная проблема: определение, риски, подходы к диагностике и профилактике сахарного диабета 2 типа и сердечно-сосудистых осложнений //Российский кардиологический журнал. – 2019. – Т. 24. - №. 4. - С. 83–91. [Barbarash O.L. et al. Pre-diabetes as an interdisciplinary problem: definition, risks, approaches to the diagnostics and prevention of type 2 diabetes and cardiovascular complications //Rossijskij kardiologicheskij zhurnal (Russian Journal of Cardiology). - 2019. - V. 24. - №. 4. - P. 83–91. In Russian]. doi: 10.15829 /1560-4071-2019-4-83-91.
8. Warren B. et al. Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study //The Lancet Diabetes & endocrinology. – 2017. – №. 5. – P. 34–42. doi: 10.1016/S2213-8587(16)30321-7.
9. Richter B. et al. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia ('prediabetes') //Cochrane Database of Systematic Reviews. – 2018. – № 10. doi: 10.1002/14651858.CD012661.pub2.
10. Kuehn B. Prediabetes in Youth //Jama. – 2020. – V.323. - №4. – P.302. doi: 10.1001/jama.2019.21122.
11. Meijnikman A.S. et al. Predicting type 2 diabetes mellitus: a comparison between the FINDRISC score and the metabolic syndrome // Diabetology & metabolic syndrome. – 2018. – V. 10. – P. 12. doi: 10.1186/s13098-018-0310-0.
12. Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance. National Diabetes Data Group //Diabetes. – 1979. – V. 28. - № 12. – P. 1039-1057. doi: 10.2337/diab.28.12.1039.
13. Mukai N. et al. Thresholds of various glycemic measures for diagnosing diabetes based on prevalence of retinopathy in community-dwelling Japanese subjects: the Hisayama Study //Cardiovascular diabetology. – 2014. – V.13. – №. 1. – P. 1-10. doi: 10.1186/1475-2840-13-45.
14. Sallar A., Dagogo-Jack S. Regression from prediabetes to normal glucose regulation: State of the science //Experimental Biology and Medicine. - 2020. – V. 245. - № 10. - P. 889-896. doi: 10.1177/1535370220915644.
15. Abdul-Ghani M.A., Tripathy D., DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose //Diabetes Care. – 2006. – V. 29. P. 1130–1139. doi: 10.2337/dc05-2179.
16. Unwin N. et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. //Diabetic medicine. – 2002. – V.19. – № 9. - P. 708–723. doi: 10.1046/j.1464-5491.2002.00835.x.
17. Genuth S. et al. Follow-up report on the diagnosis of diabetes mellitus //Diabetes Care. – 2003. – V. 26. - P.3160–3167. doi: 10.2337/diacare.26.11.3160.
18. Abdul-Ghani M.A. et al. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study //Diabetes. – 2006. – V.55. – P. 1430–1435. doi: 10.2337/db05-1200.
19. Soderberg S. et al. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius //Journal of internal medicine. – 2004. – V. 256. – P. 37–47. doi: 10.1111/j.1365-2796.2004.01336.x.
20. DeFronzo R.A., Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose //The American journal of cardiology. – 2011. – V. 108. – P. 3B–24B. doi: 10.1016/j.amjcard.2011.03.013.
21. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group //Diabetes. – 1979. – V. 28. – P. 1039–1057.
22. Stern K.G., Reiner M., Silber R.T.H. On the Electrophoretic Pattern of Red Blood Cell Proteins. A preliminary study //Journal of Biological Chemistry. - 1945. – V. 161. - P.731-738.
23. Kunkel H., Wallenius G. New hemoglobins in normal adult blood //Science. – 1955. – V. 122. – Iss. 3163. – P. 288. doi: 10.1126/science.122.3163.288
24. Аllen D.W., Schroeder W.A., Balog J. Observations on the Chromatographic Heterogeneity of Normal Adult and Fetal Human Hemoglobin: A Study of the Effects of Crystallization and Chromatography on the Heterogeneity and Isoleucine Content //Journal of the American Chemical Society. - 1958. – V. 80. – P. 1628–1634. doi: 10.1021/ja01540a030.
25. Huisman T.H., Martis E.A., Dozy A. Chromatography of Hemoglobin Types on Carboxymethylcellulose //The Journal of laboratory and clinical medicine. – 1958. – V.52. - №2. - P. 312-327.
26. Rahbar S. An Abnormal Hemoglobin in Red Cells of Diabetics //Clinica chimica acta. – 1968. – V.22. - №. 2. - P. 296-298. doi: 10.1016/0009-8981(68)90372-0.
27. Koenig R.J. et al. Hemoglobin A1C as an indicator of the degree of glucose intolerance in diabetes //Diabetes. – 1976. – V. 25. - P. 230–232. doi: 10.2337/diab.25.3.230.
28. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. The International Expert Committee //Diabetes Care. -2009. – V.32. - №. 7. - P. 1324-1334. doi: 10.2337/dc09-9033.
29. Топунов А.Ф., Космачевская О.В. Множественные функциональные формы гемоглобина в организме человека: современный взгляд и практическое использование //Биомика. - 2018. - Т.10. - №3 - С. 251-267. [Topunov A.F., Kosmachevskaya O.V. Multiple hemoglobin functional forms in human organism: the modern view and practical applications //Biomika (Biomics). - 2018. - V.10 - №3. - P. 251-267. In Russian]. doi: 10.31301/2221-6197.bmcs.2018-34.
30. Kanat M. et al. The relationship between {beta}-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study //Diabetes Care. – 2011. – V. 34. – P. 1006–1010. https://doi.org/10.2337/dc10-1352.
31. Tfayli H., Lee S.J., Bacha F., Arslanian S. One-hour plasma glucose concentration during the OGTT: what does it tell about beta-cell function relative to insulin sensitivity in overweight/obese children? //Pediatric Diabetes. – 2011. – V. 12. – P. 572–579. doi: 10.1111/j.1399-5448.2011.00745.x.
32. Fiorentino T.V. et al. One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes //The Journal of Clinical Endocrinology & Metabolism. – 2018. – V. 103. – P. 3131 –3143. doi: 10.1210/JC.2016-1856.
33. Bergman M. et al. Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥155mg/dl (8.6 mmol/L). //Diabetes research and clinical practice. – 2018. – V. 146. P. 18–33. doi: 10.1016/j.diabres.2018.09.017.
34. Abdul-Ghani M.A. et al. Onehour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes //Diabetes Care. – 2008. – V. 31. – P. 1650–1655. doi: 10.2337/dc08-0225.
35. Alyass A. et al. Modelling of OGTT curve identifies 1-h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts //Diabetologia. – 2015. – V. 58. – P. 87–97. doi: 10.1007/s00125-014-3390-x.
36. Paddock E. et al. One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans //Diabetologia. – 2017. – V. 60. - P. 1704–1711. doi: 10.1007/s00 125-017-4332-1.
37. Prasanna N. S. et al. The 1h post glucose value best predicts future dysglycemia among normal glucose tolerance subjects //Journal of Diabetes and its Complications. - 2017. – V. 31. – P. 1592–1596. doi: 10.1016/j.jdiacomp.2017.07. 017.
38. Manco M. et al. One hour post-load plasma glucose and 3 year risk of worsening fasting and 2 hour glucose tolerance in the RISC cohort //Diabetologia. – 2019. – V. 62. – P. 544–548. doi: 10.1007/s00125-018-4798-5.
39. Trico D. et al. Intestinal Glucose Absorption Is a Key Determinant of 1-Hour Postload Plasma Glucose Levels in Nondiabetic Subjects //The Journal of Clinical Endocrinology & Metabolism. – 2019. – V. 104. – P. 2131–2139. doi: 10.1210/jc.2018-02166.
40. Fiorentino N.V. et al. Response to Letter to the Editor: «One-Hour Postload Hyperglycemia: Implications for Prediction andPrevention of Type 2 Diabetes» //The Journal of Clinical Endocrinology & Metabolism. – 2019. – V. 104. - №. 3. – P. 676–677. doi: 10.1210/jc.2018-01824.
41. Трифонова О.П. и др. Метаболомный анализ крови для создания цифрового образа здорового человека //Биомедицинская химия. – 2020. – Т. 66. - №. 3. - С. 216-223. [Trifonova O.P. et al. The blood metabolome analysis for creating a digital image of a healthy person. //Biomeditsinskaya khimiya (Biomedical chemistry). – 2020. – V.66. - №3. - P. 216-223. In Russian] doi: 10.18097/ PBMC20206603216.
42. Balashova E.E. et al. Metabolomic diagnostics and human digital image // Personalized medicine. - 2019. – V. 16. - №. 2. – P. 133-144. doi:10.2217/pme-2018-0066.
43. Liu J. et al. Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study //Metabolomics. – 2017. - V. 13. – №. 9. – P. 104. doi: 10.1007 /s11306-017-1239-2.
44. Bos M.M. et al. Metabolomics analyses in non-diabetic middle-aged individuals reveal metabolites impacting early glucose disturbances and insulin sensitivity //Metabolomics. – 2020. – V. 16. - №. 3. – P. 35. doi: 10.1007/s11306-020-01653-7.
45. Tolstikov V. et al. Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics //Metabolites. – 2020. – V.10. - №6. - P. 224. doi: 10.3390/metabo10060224.
46. Лохов П.Г., Лисица А.В., Арчаков А.И. Метаболомный анализ крови: назначение, реализация, интерпретация данных //Биомедицинская химия. - 2017. - Т. 63. - №. 3. - С. 232-240. [Lokhov P.G., Lisitsa A.V., Archakov A.I. Metabolomic blood test: purpose, implementation and findings interpretation //Biomedicinskaya himiya (Biomedical Chemistry). - 2017. - V. 63. - №. 3. - P. 232-240. In Russian]. doi: 10.18097/PBMC20176303232.
47. Трифонова O.П., Лохов П.Г., Арчаков А.И. Метаболомное профилирование крови //Биомедицинская химия. – 2014. – Т. 60. - №. 3. - С. 281-294. Trifonova O.P., Lokhov P.G., Archakov A.I. Metabolic profiling of human blood // Biomedicinskaya himiya (Biomedical Chemistry). - 2014. - V. 60. - №. 3. - P. 281-294. In Russian]. doi: 10.18097/pbmc20146003281.
48. Guasch-Ferre M. et al. Metabolomics in Prediabetes and Diabetes: A Systematic Review and Metaanalysis //Diabetes Care. – 2016. – V. 39. – P. 833–846. doi: 10.2337/dc15-2251.
49. Menni C. et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach //Diabetes. – 2013. – V. 62. – P. 4270–4276. doi: 10.2337/db13-0570.
50. Xu F. et al. Tavintharan S., Sum C.F., Woon K., Lim S.C., Ong C.N. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics //The Journal of Clinical Endocrinology & Metabolism. – 2013. – V. 98. - №. 6. – P. E1060–1065. doi: 10.1210/jc.2012-4132
51. Sun L. et al. Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study //Diabetes Care. - 2016. – V. 39. - P. 1563–1570. doi: 10.2337/dc16-0232.
52. Weijer R.N.M. Fundamentals about onset and progressive disease character of type 2 diabetes mellitus //World Journal of Diabetes. – 2020. – V. 11. - № 5. – P. 165–181. doi: 10.4239/wjd. v11.i5.165.
53. Drogan D. et al. Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetesmellitus in a prospective, nested case control study //Clinical chemistry. – 2015. – V. 61. - P. 487–497. doi: 10.1373/clinchem.2014. 228965.
54. Peddinti G. et al. 1-Hour Post-OGTT Glucose Improves the Early Prediction of Type 2 Diabetes by Clinical and Metabolic Markers //The Journal of Clinical Endocrinology & Metabolism. – 2019. - V.104. - №. 4. – P. 1131–1140. doi: 10.1210/jc.2018-01828.
55. Liu X. et al. Discovery and comparison of serum biomarkers for diabetes mellitus and metabolic syndrome based on UPLC-Q-TOF/MS //Clinical Biochemistry. – 2020. – V. 82. - P. 40-50. doi: 10.1016/j.clinbiochem.2020.03.007.
56. Hasanpour M., Iranshahy M., Iranshahi M. The application of metabolomics in investigating anti-diabetic activity of medicinal plants //Biomedicine & Pharmacotherapy. – 2020. – V. 128. – P.110263. doi: 10.1016/j.biopha.2020. 110263.
57. Xu Y. J., Liu Y. Metabolomics to Study the Therapeutic Value of Natural Compounds to Treat Obesity, Reference Module in Food Science, Elsevier, 2020. doi:10.1016/b978-0-08-100596-5.22885-0.
58. Wishart D. S. NMR metabolomics: A look ahead //Journal of Magnetic Resonance. – 2019. - V. 306. – P. 155-161. doi: 10.1016/j.jmr.2019.07.013.
59. Ismailov A. S., Kuspaev E. N., Fursov A. B. Analysis of the reasons of development of lethal cases of surgical patients //The FASEB Journal. – 2015. – V. 29. – №. 1 supplement. – P. LB686. doi: 10.1096/fasebj.29.1_supplement.C. LB686.
60. Imashev M. et al. Gastroduodenal Bleeding and Perforation in Diabetic Patients with Metabolic Syndrome (The Results of a 15-Year Observation of City Residents with Intensive Urbanization) //Iranian Journal of Public Health. – 2019. – V. 48. – №. 10. – P. 1786-1793. doi: 10.18502/ijph.v48i10.3484
61. Bergman M. et al. Review of methods for detecting glycemic disorders //Diabetes Research and Clinical Practice. – 2020. – V. 165. – N. 108233. – P. 1 – 34. doi: 10.1016/j.diabres.2020.108233.